-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$1.6391.76% Upside
Kronos Bio, Inc. Frequently Asked Questions
-
What analysts cover Kronos Bio, Inc.?
Kronos Bio, Inc. has been rated by research analysts at Piper Sandler, H.C. Wainwright in the past 90 days.